Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Frederick Klauschen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9131-2389; OpenAlex author ID A5000267082, A5058109622. Sources: OpenAlex.

Their work

Papers
12
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 12

  1. Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/2056-4538.70083↗
  2. 17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing? Co-author DOI 10.1016/j.esmogo.2025.100218↗
  3. Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich LMU Molecular Tumor Board. Co-author DOI 10.1007/s11523-023-00950-0↗
  4. Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy. Co-author DOI 10.1200/po.22.00650↗
  5. Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging. Co-author DOI 10.3390/biology10101033↗
  6. TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO… Co-author DOI 10.1158/1078-0432.ccr-19-3034↗
  7. Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture. Co-author DOI 10.1186/s12885-020-06929-8↗
  8. Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicat… Co-author DOI 10.1097/mpa.0000000000000248↗
  9. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000077↗
  10. High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/1471-2407-13-450↗
  11. High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer. Co-author DOI 10.1111/j.1365-2559.2012.04225.x↗
  12. Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. Co-author DOI 10.1245/s10434-011-2041-4↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Florian Nino Loch · 3 shared papers, 2020–2026 · strength 0.51
  2. Carsten Kamphues · 7 shared papers, 2012–2021 · strength 0.40
  3. Steffen Ormanns · 2 shared papers, 2023 · strength 0.29
  4. Kathrin Heinrich · 2 shared papers, 2023 · strength 0.29
  5. Volker Heinemann · 2 shared papers, 2023 · strength 0.29
  6. Georg Beyer · 2 shared papers, 2023 · strength 0.29
  7. Christoph Benedikt Westphalen · 2 shared papers, 2023 · strength 0.29
  8. Mihnea Paul Dragomir · 1 shared paper, 2026 · strength 0.28
  9. Simon Schallenberg · 1 shared paper, 2026 · strength 0.28
  10. Deema Sabtan · 1 shared paper, 2026 · strength 0.28
  11. Marcus Bahra · 6 shared papers, 2012–2020 · strength 0.26
  12. Katharina Beyer · 2 shared papers, 2020–2021 · strength 0.23
  13. Georgios Antonios Margonis · 2 shared papers, 2020–2021 · strength 0.23
  14. Bruno Valentin Sinn · 5 shared papers, 2012–2020 · strength 0.23
  15. Albrecht Stenzinger · 5 shared papers, 2012–2015 · strength 0.17
  16. Enrico Narciso De Toni · 1 shared paper, 2023 · strength 0.16
  17. Jana Käthe Striefler · 3 shared papers, 2012–2020 · strength 0.15
  18. Carsten Denkert · 3 shared papers, 2012–2020 · strength 0.15
  19. Hanno B. Riess · 3 shared papers, 2012–2020 · strength 0.15
  20. Wilko Weichert · 4 shared papers, 2012–2015 · strength 0.14
  21. Danmei Zhang · 1 shared paper, 2023 · strength 0.13
  22. Michael Haas · 1 shared paper, 2023 · strength 0.13
  23. Bernhard Willibald Renz · 1 shared paper, 2023 · strength 0.13
  24. Elisabetta Goni · 1 shared paper, 2023 · strength 0.13
  25. Jan Goesta D’Haese · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.